In this study, we demonstrated that rs3212961 decreased HCC risk by 0.66-fold under the dominant model, but the detailed underlying mechanism should be investigated, especially whether this polymorphism influence the expression of ERCC1 exon 3 or influence the selective splicing. The gene discussed is ERCC1; the disease is hepatocellular carcinoma.